2026-01-27 - Analysis Report
### Company Overview
Intuitive Surgical is a medical device company that designs, manufactures, and markets robot-assisted surgical systems.

### Return Rate Comparison
| Ticker | Cumulative Return |
| --- | --- |
| ISRG | 202.48% |
| VOO | 127.58% |
| Divergence | 73.30 |
| Relative Divergence | 47.80% |

### Analysis
The cumulative return of ISRG exceeds that of the S&P 500 (VOO) by 74.9%. This indicates a more significant increase in stock value over the same period. As the market risk indicator (MRI) values at 0.70, the recommended investment level is Medium.

### Historical Alpha and Beta Analysis
| Year Range | CAGR | MDD | Alpha | Beta | Market Cap |
| --- | --- | --- | --- | --- | --- |
| 2016-2018 | 66.0% | 21.8% | 57.0% | 1.2 | $57.2B |
| 2017-2019 | 73.0% | 21.8% | 48.0% | 1.4 | $70.6B |
| 2018-2020 | 54.0% | 39.7% | 30.0% | 1.2 | $97.8B |
| 2019-2021 | 89.0% | 39.7% | 25.0% | 1.2 | $128.8B |
| 2020-2022 | 13.0% | 45.7% | 8.0% | 1.2 | $95.1B |
| 2021-2023 | 12.0% | 45.7% | -6.0% | 1.4 | $120.9B |
| 2022-2024 | 107.0% | 36.7% | 78.0% | 1.3 | $187.1B |
| 2023-2025 | 152.0% | 27.8% | 77.0% | 1.2 | $203.0B |

### Historical Moving Averages
| Duration | SMA Value |
| --- | --- |
| 5-day | $525.95 |
| 20-day | $558.22 |
| 60-day | $559.46 |

### RSI, PPO Index Indicators, and Expected Return Analysis
| Indicator | Value |
| --- | --- |
| RSI | 32.40 |
| PPO | -0.99 |
| MRI | 0.70 |
| Expected Return (%) | 70.30% |

### Recent News and Events Analysis
Recently, ISRG reported Q4 earnings and revenue beats, but with declining gross margins.

### Analyst Opinions
| Analyst Consensus | |
| --- | --- |
| Key: Buy | |
| Mean (1=StrongBuy~5=Sell): 2.06 (~Buy) | |
| Opinions: 30 | |
| Target Price (avg/high/low): $608.55 / $750.00 / $378.00 | |

### Recent Earnings Analysis
| Quarter | EPS | Revenue |
| --- | --- | --- |
| 2025-10-22 | $1.98 | $2.51B |
| 2025-07-23 | $1.84 | $2.44B |
| 2025-04-23 | $1.95 | $2.25B |
| 2024-10-18 | $1.59 | $2.04B |

### Revenue and Profitability Analysis
| Quarter | Revenue | Profit Margin |
| --- | --- | --- |
| 2025-09-30 | $2.51B | 66.36% |
| 2025-06-30 | $2.44B | 66.31% |
| 2025-03-31 | $2.25B | 64.69% |
| 2024-12-31 | $2.41B | 68.04% |

### Capital and Profitability Analysis
| Quarter | Equity | ROE |
| --- | --- | --- |
| 2025-09-30 | $16.93B | 4.16% |
| 2025-06-30 | $17.85B | 3.69% |
| 2025-03-31 | $17.11B | 4.08% |
| 2024-12-31 | $16.43B | 4.17% |

### Comprehensive Analysis Summary
- ISRG's cumulative return is significantly higher than the S&P 500 (VOO) by 74.9%.
- Historical alpha and beta analysis shows a moderate to high beta, indicating significant market exposure.
- RSI and PPO index indicators suggest a potentially undervalued stock.
- Analyst opinions are moderately positive, with an average target price of $608.55.
- Recent earnings and revenue beats are offset by declining gross margins.
- Financial information shows steady revenue growth and moderate profit margins.

### Final Recommendations

This comprehensive analysis is neutral in nature, emphasizing caution due to the market risk indicator and declining gross margins. However, the undervalued nature of the stock and high expected return suggest potential for appreciation.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.